Dr. Tony Milici founded GeneThera in 1999. Dr. Milici was an assistant professor in the department of Molecular Pathology at the University of Texas M.D. Anderson Cancer Center. He has a Ph.D. University of Rome/Stanford University California, Rome, Italy/Stanford, California; and M.D. (Medicine and Surgery) University of Rome, Rome, Italy; Dr. Milici’s specialties are in Biotechnology, Molecular Medicine, Gene Therapy and Oncology

Tannya L. Irizarry has served as Chief Administrative Officer of GeneThera since 1999. Currently, she is acting as Chief Financial Officer. Ms. Irizarry has over eighteen years of experience in the medical and biotechnology industries and SEC compliance, Ms. Irizarry worked at the University of Texas M.D. Anderson Cancer Center in the Neuro-Oncology Department and Office of Education; and at St. Joseph Hospital in the biotechnology division.

James Huang, Consulting Scientist, brings over 15 years of industrial biotechnology experience. Mr. Huang is a molecular biologist with a focus on vaccine development. He has extensive experience in clinical trials and GNP production. He has a Ph.D. from North Carolina University, a MS from National Taiwan University and a BS from National Chung Hsing University.